Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: J Allergy Clin Immunol. 2018 Jun 8;143(1):316–324.e7. doi: 10.1016/j.jaci.2018.06.001

FIG 7. Responder vs non-responder platelet activation and platelet-leukocyte aggregates.

FIG 7.

(A) Percentages of eosinophils with adherent platelets before aspirin administration are shown for each treatment arm for the responders (n=5, blue lines) and the non-responders. (B) Percentages of platelets that expressed surface CD62P are shown for the two patient subgroups, at the same timepoints. Data are expressed as mean + SE. P-values with a * are significant using a False Discovery Rate of 0.05 to correct for multiple comparisons.